###begin article-title 0
Protective Effect of Perindopril on Diabetic Retinopathy Is Associated With Decreased Vascular Endothelial Growth Factor-to-Pigment Epithelium-Derived Factor Ratio
###end article-title 0
###begin p 1
Z.Z. and H.C. contributed equally to this work.
###end p 1
###begin title 2
OBJECTIVE
###end title 2
###begin p 3
This study aimed to verify whether the decreased vascular endothelial growth factor (VEGF)-to-pigment epithelium-derived factor (PEDF) ratio can serve as an indicator for the protective effect of angiotensin-converting enzyme inhibitors (ACEIs) on diabetic retinopathy (DR) and to investigate the role of mitochondrial reactive oxygen species (ROS) in the downregulated VEGF-to-PEDF ratio.
###end p 3
###begin title 4
RESEARCH DESIGN AND METHODS
###end title 4
###begin p 5
###xml 9 13 <span type="species:ncbi:10116">rats</span>
###xml 109 115 <span type="species:ncbi:9913">bovine</span>
###xml 295 298 <span type="species:ncbi:10116">rat</span>
Diabetic rats and control animals were randomly assigned to receive perindopril or vehicle for 24 weeks, and bovine retinal capillary endothelial cells (BRECs) were incubated with normal or high glucose with or without perindopril. VEGF, PEDF, PPARgamma, and uncoupling protein-2 (UCP-2) in the rat retinas or BREC extracts were examined by Western blotting and real-time RT-PCR. The levels of VEGF and PEDF in cell culture media were examined by ELISA. Mitochondrial membrane potential (Deltapsim) and ROS production were assayed using JC-1 or CM-H2DCFDA.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin p 7
###xml 63 67 <span type="species:ncbi:10116">rats</span>
###xml 134 138 <span type="species:ncbi:10116">rats</span>
The VEGF-to-PEDF ratio was increased in the retina of diabetic rats; perindopril lowered the increased VEGF-to-PEDF ratio in diabetic rats and ameliorated the retinal damage. In BRECs, perindopril lowered the hyperglycemia-induced elevation of VEGF-to-PEDF ratio by reducing mitochondrial ROS. We found the decreased ROS production was a result of perindopril-induced upregulation of PPARgamma and UCP-2 expression and the subsequent decrease of Deltapsim.
###end p 7
###begin title 8
CONCLUSIONS
###end title 8
###begin p 9
It is concluded that the protective effect of ACEI on DR is associated with a decreased VEGF-to-PEDF ratio, which involves the mitochondria-ROS pathway through PPARgamma-mediated changes of UCP-2. This study paves a way for future application of ACEI in treatment of DR.
###end p 9
###begin p 10
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 515 516 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 735 736 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 921 922 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 923 924 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 993 994 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1120 1121 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 677 685 <span type="species:ncbi:9606">patients</span>
Diabetic retinopathy (DR) is a major cause of blindness in the working-age population in developed countries (1), and to search for effective treatment and prevention measures has long been a focus of study. The EUCLID Study Group reported that the antihypertensive drug lisinopril, an angiotensin-converting enzyme inhibitor (ACEI), reduced the risk of retinopathy progression by approximately50% in patients with type 1 diabetes, thus greatly reducing the possibility of proliferative diabetic retinopathy (PDR) (2). Recently, another ACEI, perindopril, has been found capable of improving the visual functions, retinal electrogenesis, and disturbed blood-retinal barrier in patients with preproliferative diabetic retinopathy (DR) (3). Studies also indicated that the protective effect of ACEI on DR-related damage was associated with a decreased expression of vascular endothelial growth factor (VEGF) in the retina (4,5), and VEGF was involved in vascular leakage and angiogenesis in DR (6). Our previous study demonstrated that ACEI inhibited retinal VEGF expression independent of their antihypertensive actions (7). The detailed mechanism by which ACEI counteracts hyperglycemia-induced VEGF upregulation, however, remains to be further clarified.
###end p 10
###begin p 11
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 691 691 691 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12"/>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
In addition to VEGF, pigment epithelium-derived factor (PEDF), a potent inhibitor of angiogenesis, has been found to be involved in the pathogenesis of PDR (8,9). It is well known that there are quite a few stimulators and inhibitors of angiogenesis in the eye; among them, VEGF has been identified as a primary angiogenic stimulator (10) and PEDF as a major angiogenic inhibitor (9). The time course of the VEGF-to-PEDF ratio change correlated with the development and progression of retinal neovascularization. The VEGF-to-PEDF ratio represented a dynamic balance between angiogenic stimulators and inhibitors; and disturbance of the balance played a key role in the pathogenesis of DR (11-13). In vitro study revealed that lowering of the VEGF-to-PEDF mRNA ratio could inhibit the migration of uveal melanoma cells (14). Despite these findings, the influence of ACEI on the VEGF-to-PEDF ratio remains unknown.
###end p 11
###begin p 12
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 477 477 477 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16"/>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 789 793 <span type="species:ncbi:10116">rats</span>
Currently, the specific mechanism of diabetic microangiopathy is not completely understood. Recently, a unifying hypothesis has been proposed whereby production of mitochondrial reactive oxygen species (ROS) in response to chronic hyperglycemia might be the key initiator for all of the four pathogenic pathways: the increased polyol pathway flux, increased formation of advanced glycation end products, activation of protein kinase C, and increased hexosamine pathway flux (15-17). This postulate emphasized the important role of the increased mitochondrion ROS production in diabetes complications, including retinopathy. Therefore, mitochondrial ROS may serve as an important target for DR treatment. ACEI was demonstrated to attenuate ROS generation in the heart and aorta of diabetic rats and prevent morphological changes (cardiomyocyte hypertrophy and perivascular fibrosis) (18). It can be deduced that the protective effect of ACEI is associated with repression of oxidative stress.
###end p 12
###begin p 13
The aim of the present study is to verify whether the decreased VEGF-to-PEDF ratio can serve as an indicator for the protective effect of ACEI on DR and to investigate the role of ROS in the downregulation of the VEGF-to-PEDF ratio and the related mechanism. We found that the decreased VEGF-to-PEDF ratio was associated with the protective effect of ACEI on DR, and the decrease of VEGF-to-PEDF ratio was caused by reduced mitochondrial ROS production; our study further indicated that the reduced ROS production was a result of ACEI-induced upregulation of PPARgamma and uncoupling protein-2 (UCP-2) expression. Our findings indicate that ACEI possesses a great potential for treatment of DR.
###end p 13
###begin title 14
RESEARCH DESIGN AND METHODS
###end title 14
###begin p 15
All experiments in this study comply with the requirements of the Association for Research in Vision and Ophthalmology statement with regard to the "Use of Animals in Ophthalmic and Vision Research." All chemicals were reagent grade quality and were purchased from Sigma Chemicals (St. Louis, MO) unless stated otherwise.
###end p 15
###begin title 16
Animals.
###end title 16
###begin p 17
###xml 450 452 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 456 458 444 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 20 39 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 230 234 <span type="species:ncbi:10116">Rats</span>
###xml 388 392 <span type="species:ncbi:10116">rats</span>
###xml 564 568 <span type="species:ncbi:10116">rats</span>
###xml 610 614 <span type="species:ncbi:10116">rats</span>
###xml 643 646 <span type="species:ncbi:10116">rat</span>
###xml 681 685 <span type="species:ncbi:10116">rats</span>
Eight-week-old male Sprague-Dawley rats weighing approximately200 g (Shanghai Laboratory Animal Center, Chinese Academy of Sciences) were randomly assigned to receive either 60 mg/kg STZ intraperitoneally or citrate buffer alone. Rats were categorized as diabetic when the blood glucose exceeded 16.7 mmol/l at 48 h after STZ administration. One week after the injection of STZ, diabetic rats were randomly assigned to groups receiving either 2 mg.kg-1.day-1 perindopril (Servier, Tianjin, China) by drinking water for 24 weeks or no treatment at all. Age-matched rats receiving no STZ served as controls. All rats had free access to standard rat food and drinking water. Diabetic rats received subcutaneous insulin (Humulin-N; Eli Lilly & Co., Indianapolis, IN) twice a week to maintain body weight and maximize survival rate (0-4 units).
###end p 17
###begin title 18
Cell culture.
###end title 18
###begin p 19
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 453 454 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 455 456 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 23 29 <span type="species:ncbi:9913">bovine</span>
The primary culture of bovine retinal capillary endothelial cells (BRECs) was done as described in our previous study (19). The endothelial cells of three to four passages were used in the following experiments. In each case, the confluent-cultured BRECs were maintained in free-serum DMEM. The cells were exposed to normal glucose (5 mmol/l), normal glucose plus mannitol (25 mmol/l), normal glucose plus perindopril (10 mumol/l), normal glucose plus H2O2 (500 mumol/l), high glucose (30 mmol/l), high glucose plus perindopril (10 mumol/l), high glucose plus ROS scavenger N-acetylcysteine (NAC; 10 mmol/l), high glucose plus perindopril plus NAC, or high glucose plus perindopril plus NAC plus GW9662 (an inhibitor of PPARgamma; 20 mumol/l).
###end p 19
###begin title 20
Uncoupling protein-2 antisense oligonucleotide treatment.
###end title 20
###begin p 21
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
UCP-2 antisense oligonucleotide synthesis and treatment were conducted as described previously (20). UCP-2 antisense oligonucleotide sequence was 5'-TGAGATCTGCAATACA-3', and the corresponding sense oligonucleotide sequence was 5'-TGTATTGCAGATCTCA-3'. After 24 h, the medium was removed, free-serum DMEM in high glucose was added, and the cells were allowed to recover for 30 min. Then BRECs were washed once with free-serum DMEM and exposed to either normal glucose (5 mmol/l) or high glucose (30 mmol/l) for 24 h.
###end p 21
###begin title 22
Retinal digest procedures.
###end title 22
###begin p 23
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 541 543 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
Harvested eyes were immediately placed in 4% buffered paraformaldehyde for 24 h. Retinal trypsin digestion was performed according to the method described by Cogan and associates (21). Preparations of retinal vascular networks were placed onto polylysine-coated glass slides in distilled water and then dried. The preparations were stored at -20degreesC until periodic acid Schiff (PAS) and hematoxylin staining. The capillary network was investigated to determine the numbers of pericytes and acellular capillaries as previously described (22).
###end p 23
###begin title 24
Transmission electron microscopy.
###end title 24
###begin p 25
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Tissue processing, electron microscopy, morphometric measurements (retinal capillary basement membrane thickness [BMT]), and statistics were performed as detailed in our previous study (6). Enucleated eyes were fixed in 2.5% glutaraldehyde in 0.1 mol/l cacodylate buffer (pH 7.4) containing 0.2% tannic acid, washed in the same buffer, and postfixed in 0.5% osmium tetroxide. Tissue sections were block stained with uranyl acetate, lead stained, dehydrated through a graded series of ethanol, and embedded in epon. One-micrometer-thick sections were examined with a JEM-1200EX transmission electron microscope (JEOL, Akishima, Japan). Computer-assisted morphometric measurements (The Image Center of Beijing University of Aeronautics & Astronautics, Beijing, China) were done on electron micrographs taken from 12 randomly selected capillaries of the outer plexiform layer from four different tissue blocks of the same retina. Only cross-sectioned capillaries were considered. A total of 96 capillaries were evaluated in each experiment group.
###end p 25
###begin title 26
Measurement of ROS.
###end title 26
###begin p 27
###xml 210 212 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex</sub>
###xml 231 233 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">em</sub>
###xml 649 650 632 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 651 652 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 766 768 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1304 1305 1273 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
ROS production in the cells was assessed using the fluorescent probe 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA; Molecular Probes, Eugene, OR). CM-H2DCFDA (lambdaex, 488 nm and lambdaem, 520 nm) is a cell-permeable indicator of ROS that remains nonfluorescent until acetate groups are removed (H2DCF) by intracellular esterases and oxidation occurs within the cells. Two hundred microliters of the cell suspension were loaded into the wells of a FluoroNunc 96-well polystyrene plate together with CM-H2DCFDA (10 mumol/l) for 45 min at 37degreesC. Intracellular ROS production was calculated using an H2O2 standard curve (10-200 nmol/ml). Retinal mitochondria ROS production was detected as described by Benani et al. (23). Retinal tissues were harvested in cold-buffered medium (5 mmol/l HEPES in PBS) and immediately frozen in liquid nitrogen to improve the following probe diffusion. After rapid thawing, medium was discarded. Samples were exposed to 8 mumol/l CM-H2DCFDA dissolved in 400 mul fresh medium and were incubated at 37degreesC for 30 min under agitation. Medium was then removed, and samples were further incubated in a lysis buffer (0.1% SDS, Tris-HCl, pH 7.4) for 15 min at 4degreesC. After homogenization, samples were centrifuged at 6,000g for 20 min at 4degreesC. Supernatants were collected and subjected to fluorescence analysis as stated previously.
###end p 27
###begin title 28
Mitochondrial membrane potential.
###end title 28
###begin p 29
###xml 671 673 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 674 676 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
5,5',6,6'-tetrachloro1,1',3,3'-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1; Molecular Probes) is a potentiometric dye that exhibits membrane potential-dependent loss as J-aggregates (polarized mitochondria) that are converted to JC-1 monomers (depolarized mitochondria) as indicated by the fluorescence emission shift from red to green. Mitochondrial depolarization is indicated by an increase in the green/red fluorescence intensity ratio. Mitochondrial membrane potential (Deltapsim) measurement in BRECs or retinal tissues was performed using flow cytometry (Coulter Epics XL; Beckman-Coulter) as described in our previous study and by Hassouna and associates (19,24).
###end p 29
###begin title 30
Real-time RT-PCR.
###end title 30
###begin p 31
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Total RNA was extracted from rat retinal tissue and BRECs using TRIZOL reagent (Invitrogen Life Technologies, Gaithersburg, MD) and stored at -80degreesC. The DyNAmo Flash SYBR Green qPCR kit (Finnzymes Oy, Espoo, Finland) was used according to the manufacturer's instructions. The primer sequences (sense/antisense) used were as follows: PEDF, 5'-CAGAAGAACCTCAAGAGTGCC-3'/5'-CTTCATCCAAGTAGAAATCC-3'; VEGF, 5'-GCGGGCTGCTGCAATG-3'/5'-TGCAACGCGAGTCTGTGTTT-3'; UCP-2, 5'-TCTGACCATGGTGCGTACTGA-3'/5'-GACAATGGCATTACGAGCAAC-3'; PPARgamma1, 5'-TTCTGACAGGACTGTGTGACAG-3'/5'-ATAAGGTGGAGATGCAGGTTC-3'; PPARgamma2, 5'-GCTGTTATGGGTGAAACTCTG-3'/5'-ATAAGGTGGAGATGCAGGTTC-3'; and beta-actin, 5'-GCACCGCAAATGCTTCTA-3'/5'-GGTCTTTACGGATGTCAACG-3'. The specificity of the amplification product was determined by a melting curve analysis. Standard curves were generated for the expression of each gene by preparing serial dilutions with known quantities of each cDNA template. Relative quantification of the signals was performed by normalizing the signals of different genes with the beta-actin signal. Signal intensities in the control lanes were arbitrarily assigned a value of 1.0.
###end p 31
###begin title 32
Western blotting.
###end title 32
###begin p 33
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 885 889 <span type="species:ncbi:9925">goat</span>
###xml 946 951 <span type="species:ncbi:10090">mouse</span>
###xml 1008 1014 <span type="species:ncbi:9986">rabbit</span>
###xml 1065 1071 <span type="species:ncbi:9986">rabbit</span>
Retinas were removed rapidly and frozen in liquid nitrogen. The frozen tissues were homogenized with lysis buffer (50 mmol/l Tris-HCl [pH 7.4], 10% glycerol, 2 mmol/l EDTA, 150 mmol/l NaCl, 1 mmol/l MgCl2, 50 mmol/l glycerophosphate, 2 mmol/l Na3VO4, 20 mmol/l NaF, 1 mmol/l phenylmethylsulfonylfluoride, 10 mug/ml leupeptin, 10 mug/ml aprotinin, and 1% Nonidet P-40) and were centrifuged at 12,000 rpm for 15 min at 4degreesC. BREC extracts were prepared with the same lysis buffer. The protein concentrations in the supernatants were measured using the Bio-Rad DC protein assay. Fifty micrograms of protein from each sample (retinas or BRECs) were subjected to SDS-PAGE using a Bio-Rad miniature slab gel apparatus and electrophoretically transferred onto a nitrocellulose sheet. The sheet was blocked in 5% nonfat dried milk solution and incubated overnight with partially purified goat anti-PEDF (Chemicon International) monoclonal antibody, mouse anti-VEGF (Chemicon, Temecula, CA) monoclonal antibody, rabbit anti-UCP-2 polyclonal antibody (Merck & Co.), and rabbit anti-PPARgamma polyclonal antibody (MILLIPORE). beta-Actin (monoclonal anti-beta-actin; Sigma Chemical) expression was used as an internal control.
###end p 33
###begin title 34
ELISA.
###end title 34
###begin p 35
###xml 312 317 <span type="species:ncbi:9606">human</span>
The PEDF concentrations in cell media were measured using a 2-antibody sandwich ELISA. Assays were performed in 96-well immunoplates (Chemicon International). VEGF ELISA was performed using a Quantikine VEGF assay kit (R & D Systems) to quantify the levels of VEGF in cell media. Serial dilutions of recombinant human VEGF and PEDF were included in all assays to serve as standards.
###end p 35
###begin p 36
###xml 290 291 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The experimental data were expressed as means +/- SD. Group means were compared by a one-way ANOVA using the GraphPad Prism 4.0 software system (GraphPad, San Diego, CA) and the statistical software program SPSS13.0 for Windows (Chicago, IL). Pearson correlation tests were also performed. P values <0.05 were considered significant in all cases.
###end p 36
###begin title 37
RESULTS
###end title 37
###begin title 38
###xml 100 104 <span type="species:ncbi:10116">rats</span>
Perindopril inhibited the increase of VEGF-to-PEDF ratio and attenuated retinal damages in diabetic rats.
###end title 38
###begin p 39
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 302 308 302 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</italic>
###xml 393 399 393 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 620 621 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 631 637 631 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 637 640 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D&#8211;F</italic>
###xml 862 869 862 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 961 967 961 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 967 970 967 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</italic>
###xml 1015 1021 1015 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1021 1024 1021 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;F</italic>
###xml 1139 1146 1139 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1323 1324 1319 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1450 1451 1442 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1639 1640 1625 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 84 88 <span type="species:ncbi:10116">rats</span>
###xml 127 131 <span type="species:ncbi:10116">rats</span>
###xml 242 246 <span type="species:ncbi:10116">rats</span>
###xml 285 289 <span type="species:ncbi:10116">rats</span>
###xml 369 373 <span type="species:ncbi:10116">rats</span>
###xml 435 439 <span type="species:ncbi:10116">rats</span>
###xml 492 496 <span type="species:ncbi:10116">rats</span>
###xml 955 959 <span type="species:ncbi:10116">rats</span>
###xml 1241 1245 <span type="species:ncbi:10116">rats</span>
###xml 1270 1274 <span type="species:ncbi:10116">rats</span>
###xml 1396 1400 <span type="species:ncbi:10116">rats</span>
###xml 1490 1494 <span type="species:ncbi:10116">rats</span>
###xml 1528 1532 <span type="species:ncbi:10116">rats</span>
###xml 1583 1587 <span type="species:ncbi:10116">rats</span>
The retinal expression of PEDF and VEGF was significantly increased in the diabetic rats compared with that in the nondiabetic rats at both mRNA and protein levels, whereas the VEGF-to-PEDF ratio was still significantly increased in diabetic rats compared with that in the nondiabetic rats (P < 0.01) (Fig. 1A-C). Pathological damage of the retina occurred in diabetic rats at an early stage (Fig. 2A-C). Compared with the nondiabetic rats, the number of pericytes in the retinas of diabetic rats was significantly reduced (P < 0.01), and the number of acellular capillary segments and BMT were significantly increased (P < 0.01) (Fig. 2D-F). Statistical analysis showed that the VEGF-to-PEDF ratio was negatively correlated with the number of pericytes and positively correlated with acellular capillary segments and BMT before and after perindopril treatment (Table 1). Perindopril significantly inhibited the increase of VEGF-to-PEDF ratio in diabetic rats (Fig. 1A-C) and attenuated the damages to the retinas (Fig. 2A-F), and the decrease of the VEGF-to-PEDF ratio was significantly correlated with the attenuation of retinal damage (Table 1). In addition, we found that the nonfasting blood glucose was markedly higher in the diabetic rats than in the nondiabetic rats (28.5 +/- 4.3 mmol/l versus 4.3 +/- 0.5 mmol/l, P < 0.01), and perindopril showed no effect on hyperglycemia in diabetic rats (27.3 +/- 3.8 mmol/l versus 28.5 +/- 4.3 mmol/l, P > 0.05). The body weights of diabetic rats and perindopril-treated diabetic rats were significantly lower than that of nondiabetic rats (377 +/- 28 g or 392 +/- 36 g versus 594 +/- 45 g, P < 0.05).
###end p 39
###begin p 40
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 421 422 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 792 793 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 818 819 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 91 95 <span type="species:ncbi:10116">rats</span>
###xml 116 120 <span type="species:ncbi:10116">rats</span>
###xml 122 124 <span type="species:ncbi:10116">DM</span>
###xml 140 144 <span type="species:ncbi:10116">rats</span>
###xml 171 173 <span type="species:ncbi:10116">DM</span>
###xml 683 687 <span type="species:ncbi:10116">rats</span>
###xml 834 836 <span type="species:ncbi:10116">DM</span>
Changes of retinal VEGF and pigment epithelium-derived factor (PEDF) levels in the control rats (control), diabetic rats (DM), and diabetic rats treated with perindopril (DM + P). A: Real-time RT-PCR determination of VEGF and PEDF mRNAs relative to the control values. B: Western blotting analysis of VEGF and PEDF protein expression in the three groups. Equal protein loading was confirmed with the beta-actin antibody. C: VEGF-to-PEDF ratios (protein) in the three groups. Levels of VEGF and PEDF were first normalized by beta-actin at each time point. The normalized VEGF level was divided by the corresponding PEDF levels for VEGF-to-PEDF ratio. Data are means +/- SD from eight rats per group, and the experiments were repeated independently at least three times with similar results. **P < 0.01 versus control, #P < 0.05 versus DM.
###end p 40
###begin p 41
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 350 360 350 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrowheads</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 505 511 505 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arrows</italic>
###xml 704 705 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 706 707 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 758 759 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 792 793 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 818 819 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 883 884 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1049 1050 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1075 1076 1073 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 80 84 <span type="species:ncbi:10116">rats</span>
###xml 86 88 <span type="species:ncbi:10116">DM</span>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
###xml 135 137 <span type="species:ncbi:10116">DM</span>
###xml 472 475 <span type="species:ncbi:10116">rat</span>
###xml 940 944 <span type="species:ncbi:10116">rats</span>
###xml 1091 1093 <span type="species:ncbi:10116">DM</span>
Observation of early retinal histopathological lesions in the control, diabetic rats (DM), and diabetic rats treated with perindopril (DM + P) groups. A and B: Low- and high-magnification (x50 and x400) photomicrographs of trypsin-digested retinal blood vessels obtained from the three groups. All preparations were stained with PAS and hematoxylin; arrowheads indicate acellular capillary. C: Transmission electron micrograph of a capillary from outer plexiform layer of rat retinas in the three groups. Arrows denote the segment of the outer capillary basement membrane between the endothelial cells and glia limitans, which was used to measure basement membrane width (original magnification x9,000). D-F: Determination of pericyte/mm2 of capillary area (D), acellular capillary segment/mm2 in the retinal vessels (E), and retinal capillary basement membrane thickness (BMT, nm) (F) in the three groups. Data are means +/- SD from eight rats per group, and the experiments were repeated independently at least three times with similar results. **P < 0.01 versus control, #P < 0.05 versus DM. (A high-quality digital representation of this figure is available in the online issue.)
###end p 41
###begin p 42
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Correlation analysis between retinal VEGF-to-PEDF ratio and early histopathological lesions in diabetic rats with or without perindopril treatment (n = 8)
###end p 42
###begin p 43
###xml 0 2 <span type="species:ncbi:10116">DM</span>
###xml 13 17 <span type="species:ncbi:10116">rats</span>
###xml 19 21 <span type="species:ncbi:10116">DM</span>
###xml 36 40 <span type="species:ncbi:10116">rats</span>
DM, diabetic rats; DM + P, diabetic rats treated with perindopril.
###end p 43
###begin title 44
Decreased VEGF-to-PEDF ratio is associated with reduced mitochondrial ROS generation after perindopril treatment.
###end title 44
###begin p 45
###xml 192 193 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 333 339 313 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 339 342 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;D</italic>
###xml 517 523 497 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 523 524 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 527 528 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 538 539 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 661 662 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 713 714 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 724 725 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 776 777 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 787 788 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 26 30 <span type="species:ncbi:10116">rats</span>
###xml 186 190 <span type="species:ncbi:10116">rats</span>
Compared with nondiabetic rats, the production of mitochondrial ROS, Deltapsim, and the expression of UCP-2 and PPARgamma protein were significantly increased in the retinas of diabetic rats (P < 0.01). Perindopril treatment reduced ROS production and Deltapsim but further upregulated the expression of UCP-2 and PPARgamma protein (Fig. 3A-D). Pearson correlation analysis indicated that the decrease of the VEGF-to-PEDF ratio was correlated with the reduction of mitochondrial ROS in the perindopril-treated group (Fig. 3B) (r = 0.749, P = 0.032). In addition, statistical analysis showed that there was a correlation between mitochondrial ROS and Deltapsim (r = 0.902, P = 0.003), between Deltapsim and UCP-2 (r = 0.823, P = 0.012), and between UCP-2 and PPARgamma levels (r = 0.887, P = 0.005) in the perindopril-treated group.
###end p 45
###begin p 46
###xml 253 254 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 372 373 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 487 488 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 597 598 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 904 905 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 931 932 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 957 958 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 979 980 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 182 186 <span type="species:ncbi:10116">rats</span>
###xml 188 190 <span type="species:ncbi:10116">DM</span>
###xml 206 210 <span type="species:ncbi:10116">rats</span>
###xml 237 239 <span type="species:ncbi:10116">DM</span>
###xml 796 800 <span type="species:ncbi:10116">rats</span>
###xml 973 975 <span type="species:ncbi:10116">DM</span>
###xml 995 997 <span type="species:ncbi:10116">DM</span>
Retinal mitochondrial ROS production and membrane potential (the mitochondria suspensions were diluted to 1 mg protein/ml) and levels of UCP-2 and PPARgamma in the control, diabetic rats (DM), and diabetic rats treated with perindopril (DM + P) groups. A: Mitochondrial ROS production in the retinas of the three groups was identified by the fluorescent probe CM-H2DCFDA. B: A correlation analysis between VEGF-to-PEDF ratio and mitochondrial ROS level in the perindopril-treated group. C: Mitochondrial membrane potential (Deltapsim) in the three groups was examined by the molecular probe JC-1. D: Western blotting analysis of UCP-2 protein and PPARgamma protein expression in the three groups. Equal protein loading was confirmed with the beta-actin antibody. Data are means +/- SD from eight rats per group, and the experiments were repeated independently at least three times with similar results. *P < 0.05 versus control, **P < 0.01 versus control, #P < 0.05 versus DM, **P < 0.01 versus DM.
###end p 46
###begin title 47
Perindopril inhibited hyperglycemia-induced elevation of VEGF-to-PEDF ratio through reducing ROS production.
###end title 47
###begin p 48
###xml 481 487 480 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 487 490 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;F</italic>
###xml 675 676 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 677 678 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 773 779 772 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 779 782 778 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;F</italic>
###xml 800 801 799 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 802 803 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To understand the mechanism underling the inhibitory effect of perindopril on the VEGF-to-PEDF ratio, an in vitro study was performed with BRECs. Exposure of BRECs to high glucose increased ROS production, upregulated VEGF mRNA and protein in cell extracts or media, downregulated PEDF mRNA and protein in cell extracts or media, and elevated the VEGF-to-PEDF ratio (protein in cell extracts or media), whereas these changes were significantly inhibited by 10 mumol/l perindopril (Fig. 4A-F). Our results also showed that NAC, an ROS scavenger, arrested the elevation of the VEGF-to-PEDF ratio (upregulating VEGF and downregulating PEDF). We also found that incubation with H2O2 upregulated VEGF, downregulated PEDF, and elevated VEGF/PEDF ratio in BREC extracts or media (Fig. 5A-F). The effect of H2O2 on VEGF-to-PEDF ratio was time- and dose-dependent (data not shown). To rule out the influence of osmolarity on the ratio, mannitol was used to treat the cells, and the results showed that mannitol had no effect on the VEGF-to-PEDF ratio (data not shown).
###end p 48
###begin p 49
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 499 500 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 655 656 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 678 679 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 684 685 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1194 1195 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1216 1217 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ROS production and levels of VEGF and PEDF in BRECs exposed to normal glucose (NG) or high glucose (HG). A: Intracellular ROS production was determined by the fluorescent probe CM-H2DCFDA in BRECs exposed to NG, HG, HG + perindopril (HG + P), HG + UCP-2 sense, HG + UCP-2 antisense, or HG + P + UCP-2 antisense for 24 h. B: VEGF and PEDF mRNAs in BRECs were determined by real-time RT-PCR in NG, HG, HG + P, or HG with NAC (HG + NAC) for 72 h. Results are expressed relative to the NG values. C and E: Western blotting analysis of VEGF and PEDF protein expression in BREC extracts (C) and ELISA analysis of VEGF and PEDF protein expression in BREC media (E) in the four groups. D and F: VEGF-to-PEDF ratios (protein in BRECs extracts [D] and in BREC media [F]) in the four groups. Levels of VEGF and PEDF were first normalized by beta-actin at each time point in Western blotting; the normalized VEGF level was divided by the corresponding PEDF levels for calculation of VEGF-to-PEDF ratio. Data are means +/- SD from nine cells per group, and the experiments were repeated independently at least three times (real-time RT-PCR and Western blotting) or two times (ELISA) with similar results. **P < 0.01 versus NG, ##P < 0.01 versus HG.
###end p 49
###begin p 50
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 75 77 75 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2.</sub>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 177 178 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 335 336 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 739 740 737 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Levels of VEGF and PEDF in BRECs exposed to normal glucose (NG) or NG + H2O2.A: VEGF and PEDF mRNAs in BRECs were determined by real-time RT-PCR in the control group and the H2O2-treated group. Results are expressed as relative to the NG values. B and D: Western blotting analysis of VEGF and PEDF protein expression in BREC extracts (B) and ELISA analysis of VEGF and PEDF protein expression in BREC media (D) in the two groups. C and E: The VEGF-to-PEDF ratios (protein in BRECs extracts [C] and in BREC media [E]) in the two groups. Data are means +/- SD from nine cells per group, and the experiments were repeated independently at least three times (real-time RT-PCR and Western blotting) or two times (ELISA) with similar results. **P < 0.01 versus NG.
###end p 50
###begin title 51
Perindopril reduced ROS production through upregulating PPARgamma and UCP-2 and downregulating mitochondrial membrane potential.
###end title 51
###begin p 52
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 262 264 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 648 649 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 659 660 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 834 841 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figs. 4</xref>
###xml 841 842 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 847 848 833 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 848 849 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 854 855 840 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1044 1050 1030 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1050 1051 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1056 1057 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1274 1281 1248 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figs. 4</xref>
###xml 1281 1282 1255 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1287 1288 1261 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1288 1289 1262 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1294 1295 1268 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1323 1329 1297 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1329 1332 1303 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</italic>
###xml 1772 1778 1730 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1778 1781 1736 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</italic>
UCP-2 expression has been reported to be associated with ROS generation (25), and PPARgamma has been shown to modulate the transcription activities of genes involved in energy metabolism, including the mitochondrial uncoupling proteins, UCP-1, UCP-2, and UCP-3 (26). To investigate the mechanism by which perindopril reduces ROS production, we examined the mRNA and protein expression of UCP-2 and PPARgamma in BRECs exposed to normal and high glucose. We found that the mitochondrial membrane was hyperpolarized under high glucose conditions and the production of ROS was increased; the production of ROS was positively correlated with Deltapsim (r = 0.779, P = 0.023); we also found that perindopril significantly decreased hyperglycemia-induced mitochondrial membrane hyperpolarization and the subsequent increased ROS production (Figs. 4A and 6A and B). We found that hyperglycemia induced upregulation of UCP-2 mRNA and protein; perindopril also upregulated UCP-2 expression in BRECs exposed to normal or high glucose with or without NAC (Fig. 6C and D). Incubation with UCP-2 antisense oligonucleotide greatly enhanced the hyperglycemia-induced Deltapsim and ROS production, whereas it blocked the inhibitory effect of perindopril on the Deltapsim and ROS production (Figs. 4A and 6A and B). In addition, as shown in Fig. 7A-C, hyperglycemia increased the expression of PPARgamma1 and PPARgamma2 mRNA and PPARgamma protein; perindopril could upregulate their expression under normal conditions and further upregulate their expression under hyperglycemia conditions. We also found that high glucose combined with GW9662, an inhibitor of PPARgamma, inhibited the upregulation of UCP-2 in BRECs; besides, GW9662 blocked the upregulating effect of perindopril on UCP-2 (Fig. 7A-C).
###end p 52
###begin p 53
###xml 71 72 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 286 287 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 393 394 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 652 653 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 987 988 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1009 1010 986 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1030 1031 1007 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1052 1053 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1073 1074 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Mitochondrial membrane potential (Deltapsim) and UCP-2 level in BRECs. A: Deltapsim in BRECs exposed to normal glucose (NG), high glucose (HG), HG + perindopril (P), HG + UCP-2 sense, HG + UCP-2 antisense, and HG + P + UCP-2 antisense for 24 h was examined by the molecular probe JC-1. B: A correlation analysis between intracellular ROS production and Deltapsim level in BRECs exposed to HG. C: UCP-2 mRNAs in BRECs exposed to NG, NG plus perindopril (NG + P), HG, HG plus perindopril (HG + P), HG plus NAC (HG + NAC), and HG plus NAC and perindopril (HG + NAC+ P) were determined by real-time RT-PCR. Results are expressed relative to the NG values. D: Western blotting analysis of UCP-2 protein expression in BRECs in NG, NG + P, HG, HG + P, HG + NAC, and HG + NAC + P groups. Equal protein loading was confirmed with the beta-actin antibody. Data are means +/- SD from nine cells per group, and the experiments were repeated independently at least three times with similar results. *P < 0.05 versus NG, **P < 0.01 versus NG, #P < 0.05 versus HG, ##P < 0.01 versus HG, $P < 0.05 versus HG + NAC.
###end p 53
###begin p 54
###xml 40 41 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 46 47 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 61 62 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 80 81 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 269 270 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 350 351 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 714 715 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 736 737 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 757 758 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 779 780 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Levels of PPARgamma and UCP-2 in BRECs. A and B: PPARgamma1 (A) and PPARgamma2 (B) mRNAs in BRECs were determined by real-time RT-PCR in normal glucose (NG), NG + perindopril (P), high glucose (HG), and HG + P for 24 h. Results are expressed relative to the NG values. C: Western blotting analysis of PPARgamma protein expression in the four groups. D: Western blotting analysis of UCP-2 protein expression in NG, HG, HG with GW9662 (HG + GW9662), HG + P, and HG plus P and GW9662 (HG + P + GW9662) groups. Equal protein loading was confirmed with the beta-actin antibody. Data are means +/- SD from nine cells per group, and the experiments were repeated independently at least three times with similar results. *P < 0.05 versus NG, **P < 0.01 versus NG, #P < 0.05 versus HG, $$P < 0.01 versus HG + P.
###end p 54
###begin title 55
DISCUSSION
###end title 55
###begin p 56
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 89 89 89 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3"/>
###xml 89 89 89 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4"/>
###xml 89 89 89 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5"/>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 415 415 415 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3"/>
###xml 415 415 415 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4"/>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 151 154 <span type="species:ncbi:10116">rat</span>
###xml 313 317 <span type="species:ncbi:10116">rats</span>
Recently, the protective effect of ACEI on DR has increasingly become a focus of study (2-6). We observed the changes of the VEGF-to-PEDF ratio in the rat retinal tissues and BRECs in the presence of normal or high glucose; we also observed the effect of perindopril on changes of the VEGF/PEDF ratio in diabetic rats and in BRECs exposed to high glucose. We confirmed that ACEI exerted a protective effect on DR (2-5,27,28), and for the first time, we found that this protective effect was associated with a decreased VEGF-to-PEDF ratio (downregulating VEGF and upregulating PEDF). We found the decreased VEGF-to-PEDF ratio was a result of reduced mitochondrial ROS production, and the reduced ROS production was attributable to decreased Deltapsim, which was a result of ACEI-induced upregulation of PPARgamma and UCP-2 expression.
###end p 56
###begin p 57
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 239 258 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 377 381 <span type="species:ncbi:10116">rats</span>
###xml 937 941 <span type="species:ncbi:10116">rats</span>
We found that VEGF was upregulated and PEDF was downregulated in the vitreous of patients with PDR, which subsequently elevated the VEGF-to-PEDF ratio and was accompanied by retinal neovascularization (data not shown), whereas in diabetic Sprague-Dawley rats, both VEGF and PEDF were upregulated. (A similar result was also noticed in a study with spontaneously diabetic Torii rats, an animal model of type 2 diabetes [(29)].) Nevertheless, as a result of even more upregulation of VEGF, the VEGF/PEDF ratio was still significantly elevated compared with that of the controls; the elevation was also accompanied by early vascular damages; and a significant correlation was found between the severity of damage and the VEGF/PEDF ratio. In this study, we found that ACEI perindopril downregulated VEGF and upregulated PEDF, which subsequently resulted in a lowered VEGF-to-PEDF ratio and relieved vascular damage in the retina of diabetic rats; and the lowering of VEGF-to-PEDF ratio was significantly correlated with the relief of the vascular damage. It is therefore indicated that the protective effect of ACEI on DR was associated with the decreased VEGF-to-PEDF ratio, which may serve as an effective marker for the development, progression, and treatment outcome of DR.
###end p 57
###begin p 58
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 244 244 244 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16"/>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 509 510 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 511 512 511 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To further explore the mechanism by which ACEI exerts its protective effect on DR, we investigated the possible role of mitochondrial ROS, which is taken as a key initiator for all of the four pathogenic pathways of diabetic microangiopathy (15-17). We found that high glucose could induce ROS production, which was consistent with our previous study (19); we also noticed that ACEI inhibited the retinal and cellular production of ROS and blocked the elevation of the VEGF-to-PEDF ratio. We discovered that H2O2 upregulated VEGF, downregulated PEDF, and elevated the VEGF-to-PEDF ratio and that NAC, an ROS scavenger, could inhibit hyperglycemia-induced changes of VEGF and PEDF expression and elevation of the VEGF-to-PEDF ratio. These findings suggest that ROS is an upstream molecule of VEGF and PEDF and that ACEI lowers the VEGF-to-PEDF ratio through inhibiting hyperglycemia-induced ROS production.
###end p 58
###begin p 59
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 435 437 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 528 530 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 531 533 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 534 536 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 283 288 <span type="species:ncbi:9606">human</span>
Hyperglycemia-induced ROS production is primarily thought to be associated with mitochondria and NADPH oxidase (30). A previous study found that both hyperglycemia and angiotensin II, through activating membrane-bound NADH-/NADPH oxidase, could induce superoxide anion generation in human vascular endothelial cells (31). ACEI was also found to inhibit TGF-beta and prevent activation of NADPH oxidase so as to attenuate renal damage (32). Mitochondrial ROS was reported to play a very important role in the pathogenesis of DR (16,17,19). Consistent with these studies, our results also revealed that hyperglycemia induced NADPH oxidase activation (data not shown) and mitochondrial membrane hyperpolarization and promoted ROS production. We noticed that perindopril suppressed hyperglycemia-induced activation of NADPH oxidase in a manner similar to that of diphenyleneiodonium in cultured BRECs under hyperglycemic conditions (data not shown).
###end p 59
###begin p 60
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 177 182 <span type="species:ncbi:9606">human</span>
We discovered, for the first time, that perindopril inhibited the mitochondrial ROS production by increasing the expression of UCP-2, homologous to UCP-1 (33), found in various human tissues, and one of its major functions is as a sensor and negative regulator of ROS production (25). We found that hyperglycemia could compensatorily upregulate UCP-2 so as to negatively modulate Deltapsim and ROS because treatment with specific UCP-2 antisense oligonucleotide could increase hyperglycemia-induced mitochondrial membrane hyperpolarization and subsequent ROS generation. We also found that perindopril upregulated UCP-2 and reduced ROS in BRECs exposed to normal glucose, high glucose, or high glucose plus NAC, indicating ACEI can directly upregulate UCP-2; meanwhile, this effect of perindopril could be blocked by the specific UCP-2 antisense oligonucleotide, suggesting that perindopril exerts it effect through UCP-2. It can be concluded that ACEI can attenuate oxidative stress through both the NADPH oxidase pathway and the UCP-2/mitochondrial pathway. In view of the important role of ROS in the pathogenesis DR, the inhibitory effect of ACEI on mitochondrial ROS production might be an important mechanism for treatment of diabetes complications.
###end p 60
###begin p 61
###xml 301 302 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 392 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 618 620 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 621 623 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 955 957 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1102 1104 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1104 1104 1048 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38"/>
###xml 1104 1104 1048 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39"/>
###xml 1105 1107 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 931 939 <span type="species:ncbi:9606">patients</span>
We also investigated the specific mechanism by which ACEI induces UCP-2 upregulation and found that PPARgamma, a ligand-activated transcription factor belonging to the nuclear receptor superfamily, was involved in the process. PPARgamma has two isoforms, gamma1 and gamma2, and they differ at their NH2 terminus, which has the same sequence except for the additional 28 amino acids at the NH2-terminus of PPARgamma2. PPARgamma2 is rich in the different adipose tissues, whereas PPARgamma1 has a broader expression pattern, including the gut, brain, vascular cells, and specific kinds of immune and inflammatory cells (34,35). The measurement of PPARgamma protein expression by anti-PPARgamma polyclonal antibody could be used to determine the total protein of PPARgamma1 and gamma2. Owing to its critical role in fat metabolism and the role of PPARgamma activators in diabetes prevention, PPARgamma has been extensively studied in patients with diabetes (36). It has been reported that PPARgamma could benefit vascular function and inhibit neovascularization, retinal leukostasis, and retinal leakage (37-40). Until now, no one has studied the effect of ACEI on PPARgamma. Our study is the first to find that perindopril could upregulate PPARgamma1 and gamma2 in BRECs exposed to normal-glucose or high-glucose conditions; besides, PPARgamma inhibitor GW9662 could inhibit the upregulation of UCP-2 expression induced by high glucose or perindopril, suggesting that the upregulation of UCP-2 expression is mediated, at least in part, by PPARgamma.
###end p 61
###begin p 62
In conclusion, our study suggests that ACEI exerts a protective effect on DR and this protective effect can be reflected by a decreased VEGF-to-PEDF ratio, which is a result of reduced mitochondrial ROS production-itself caused by ACEI-induced increase of PPARgamma and subsequent upregulation of UCP-2 expression. It is indicated that ACEI possesses a great potential for treatment of DR; a long-term prospective study based on large samples is needed to verify the clinical effect of ACEI for DR.
###end p 62
###begin p 63
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 63
###begin title 64
Acknowledgments
###end title 64
###begin p 65
This work was supported by grants from the Research Fund for the Doctoral Program of Higher Education of China (20060248077) and the National Nature Science Funding of China (30772370 and 30872828).
###end p 65
###begin p 66
No potential conflicts of interest relevant to this article were reported.
###end p 66
###begin p 67
We thank Yu Danghui of Second Military Medical University Press for his polishing of the English language.
###end p 67
###begin title 68
REFERENCES
###end title 68
###begin article-title 69
Treatment of diabetic retinopathy. 
###end article-title 69
###begin article-title 70
###xml 67 73 <span type="species:ncbi:9606">people</span>
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. 
###end article-title 70
###begin article-title 71
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Use of perindopril in the treatment of patients with diabetic retinopathy. 
###end article-title 71
###begin article-title 72
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. 
###end article-title 72
###begin article-title 73
###xml 136 144 <span type="species:ncbi:9606">patients</span>
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. 
###end article-title 73
###begin article-title 74
###xml 49 54 <span type="species:ncbi:9606">human</span>
Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. 
###end article-title 74
###begin article-title 75
###xml 141 144 <span type="species:ncbi:10116">rat</span>
Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy. 
###end article-title 75
###begin article-title 76
###xml 121 129 <span type="species:ncbi:9606">patients</span>
Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. 
###end article-title 76
###begin article-title 77
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. 
###end article-title 77
###begin article-title 78
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. 
###end article-title 78
###begin article-title 79
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. 
###end article-title 79
###begin article-title 80
###xml 145 149 <span type="species:ncbi:10116">rats</span>
Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization. 
###end article-title 80
###begin article-title 81
Upregulation of PEDF expression by PARP inhibition contributes to the decrease in hyperglycemia-induced apoptosis in HUVECs. 
###end article-title 81
###begin article-title 82
###xml 155 161 <span type="species:ncbi:10090">murine</span>
Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model. 
###end article-title 82
###begin article-title 83
Oxidative stress as a major culprit in kidney disease in diabetes. 
###end article-title 83
###begin article-title 84
Biochemistry and molecular cell biology of diabetic complications. 
###end article-title 84
###begin article-title 85
The pathobiology of diabetic complications: a unifying mechanism. 
###end article-title 85
###begin article-title 86
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. 
###end article-title 86
###begin article-title 87
Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. 
###end article-title 87
###begin article-title 88
Interleukin-1beta swiftly down-regulates UCP-2 mRNA in beta-cells by mechanisms not directly coupled to toxicity. 
###end article-title 88
###begin article-title 89
Retinal vascular patterns. IV. Diabetic retinopathy. 
###end article-title 89
###begin article-title 90
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. 
###end article-title 90
###begin article-title 91
Role for mitochondrial reactive oxygen species in brain lipid sensing: redox regulation of food intake. 
###end article-title 91
###begin article-title 92
###xml 83 88 <span type="species:ncbi:9606">human</span>
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. 
###end article-title 92
###begin article-title 93
Thermogenic mechanisms in brown fat. 
###end article-title 93
###begin article-title 94
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. 
###end article-title 94
###begin article-title 95
###xml 144 147 <span type="species:ncbi:10116">rat</span>
Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model. 
###end article-title 95
###begin article-title 96
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina. 
###end article-title 96
###begin article-title 97
###xml 68 71 <span type="species:ncbi:10116">rat</span>
High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes. 
###end article-title 97
###begin article-title 98
Renal microvascular injury in diabetes: RAGE and redox signaling. 
###end article-title 98
###begin article-title 99
###xml 54 59 <span type="species:ncbi:9606">human</span>
Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. 
###end article-title 99
###begin article-title 100
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. 
###end article-title 100
###begin article-title 101
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. 
###end article-title 101
###begin article-title 102
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. 
###end article-title 102
###begin article-title 103
###xml 24 29 <span type="species:ncbi:9606">human</span>
PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. 
###end article-title 103
###begin article-title 104
The role of PPARs in the microvascular dysfunction in diabetes. 
###end article-title 104
###begin article-title 105
Vascular effects of TZDs: new implications. 
###end article-title 105
###begin article-title 106
Response of experimental retinal neovascularization to thiazolidinediones. 
###end article-title 106
###begin article-title 107
Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. 
###end article-title 107
###begin article-title 108
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. 
###end article-title 108

